Open AccessCardiovascular Medication Use and Risk of Acute Exacerbation in Patients With Asthma-COPD Overlap (CVACO Study)
Author(s) -
Vincent Yi-Fong Su,
Szu-Wen Ko,
YuhLih Chang,
YuehChing Chou,
Hsin Chen Lee,
Kuang-Yao Yang,
Kun-Ta Chou,
Chia Chen Hsu
Publication year - 2022
Publication title -
allergy, asthma and immunology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.356
H-Index - 45
eISSN - 2092-7363
pISSN - 2092-7355
DOI - 10.4168/aair.2022.14.3.314
Subject(s) - medicine , hazard ratio , copd , asthma , exacerbation , cohort , emergency department , confidence interval , cohort study , retrospective cohort study , psychiatry
Current clinical guidelines are unclear regarding the association of cardiovascular medication with the risk of acute exacerbation (AE) in patients with asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO).